Bioxytran, Inc.

BIXT · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$2,380-$4,563-$2,657-$4,528
Dep. & Amort.$8$8$4$77
Deferred Tax$0$0$0-$77
Stock-Based Comp.$634$198$178$583
Change in WC$1,226$3,201$304$2,171
Other Non-Cash$456$310$366$77
Operating Cash Flow-$56-$775-$1,806-$1,697
Investing Activities
PP&E Inv.-$28-$44-$32-$37
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0-$44-$32-$37
Investing Cash Flow-$28-$44-$32-$37
Financing Activities
Debt Repay.$0$0$0$1,165
Stock Issued$63$550$680$600
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$1,381$0
Financing Cash Flow$63$550$2,061$1,765
Forex Effect$0$0$0$0
Net Chg. in Cash-$21-$269$223$31
Supplemental Information
Beg. Cash$26$295$72$42
End Cash$5$26$295$72
Free Cash Flow-$84-$820-$1,838-$1,734